Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals

JOURNAL OF INFECTION

W B SAUNDERS CO LTD

1. United Kingdom Department of Health and Social Care
2. United Kingdom Research and Innovation COVID-19 Rapid Response Rolling Call as part of the PITCH Consortium